HFQTX
Price
$8.29
Change
-$0.00 (-0.00%)
Updated
Aug 20 closing price
Net Assets
7.92B
TRWTX
Price
$29.84
Change
+$0.31 (+1.05%)
Updated
Aug 21 closing price
Net Assets
4.41B
Interact to see
Advertisement

HFQTX vs TRWTX

HFQTX vs TRWTX Comparison Chart in %
View a ticker or compare two or three
VS
HFQTX vs. TRWTX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HFQTX is a StrongBuy and TRWTX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HFQTX has more cash in the bank: 7.92B vs. TRWTX (4.41B). HFQTX pays higher dividends than TRWTX: HFQTX (5.99) vs TRWTX (3.32). HFQTX was incepted earlier than TRWTX: HFQTX (9 years) vs TRWTX (34 years). HFQTX (0.94) is less costly to investors than TRWTX (0.76). HFQTX is a more actively managed with annual turnover of: 175.00 vs. TRWTX (13.00). TRWTX has a lower initial minimum investment than HFQTX: TRWTX (0) vs HFQTX (2500). HFQTX annual gain was more profitable for investors over the last year : 25.77 vs. TRWTX (23.42). HFQTX return over 5 years is better than : 77.21 vs. TRWTX (58.53).
HFQTXTRWTXHFQTX / TRWTX
Total Expense Ratio0.940.76124%
Annual Report Gross Expense Ratio0.940.76124%
Fund Existence9 years34 years-
Gain YTD18.38918.55499%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.92B4.41B180%
Annual Yield % from dividends5.993.32180%
Returns for 1 year25.7723.42110%
Returns for 3 years76.9969.32111%
Returns for 5 years77.2158.53132%
Returns for 10 yearsN/A111.88-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPAX23.980.24
+1.01%
Saratoga Health & Biotechnology A
GQJIX12.860.08
+0.63%
GQG Partners Intl Qual Val Fd Ins
PSLGX150.540.73
+0.49%
Putnam Sustainable Leaders R6
GRISX34.520.15
+0.44%
Nationwide S&P 500 Index Instl Svc
TNXIX23.190.09
+0.41%
1290 Avantis U.S. Large Cap Growth I